Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 11, pp 3455–3461 | Cite as

Radiological Staging for Distant Metastases in Breast Cancer Patients with Confirmed Local and/or Locoregional Recurrence: How Useful are Current Guideline Recommendations?

  • Constanze Elfgen
  • Seraina Margaretha Schmid
  • Christoph Johannes Tausch
  • Giacomo Montagna
  • Uwe GüthEmail author
Breast Oncology

Abstract

Background

Breast cancer patients with local and/or locoregional recurrence (LR) are at higher risk of developing distant metastases (DM) at a later time. Once LR has been confirmed, some international interdisciplinary guidelines recommend performing radiological examinations for DM to determine the course of further therapy (curative or palliative approach). This study analyzed the metastatic patterns of patients with LR with particular regard to the frequency of concurrent diagnosis of LR and DM; in other words: are radiological staging procedures actually justified for DM at the time of diagnosis of LR?

Methods

This study included all patients (n = 1368) who were diagnosed and treated for nonmetastatic breast cancer (Stage I–III) at the University Women’s Hospital Basel, Switzerland between 1990 and 2009.

Results

In 137 patients, LR was diagnosed without a history of DM: in-breast/thoracic wall only, n = 90 (65.7%); involvement of axillary/supra-/infraclavicular lymph nodes, n = 47 (34.3%). DM was found at the time of diagnosis of LR in 44 patients (32.1%). Concurrent diagnosis of LR and DM occurred significantly more often in patients with lymph node recurrence compared with those with in-breast/chest wall recurrence (48.9% vs. 23.3%; p = 0.004).

Conclusions

Approximately one-third of patients with a LR had synchronous DM at the time of their local/locoregional event. For this reason, routine systemic staging imaging at the time of LR should be an absolute requirement for planning further therapy. Confirmation of DM may spare the patients radical surgical interventions with questionable impact on survival in the face of an incurable disease.

Notes

Acknowledgment

The authors thank Serenella Eppenberger-Castori from the Institute for Pathology of the University Hospital of Basel for statistical analyses.

Disclosures

The authors declare that they have no conflicts of interest to disclose.

References

  1. 1.
    van Laar C, van der Sangen MJ, Poortmans PM, et al. Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients. Eur J Cancer. 2013;49:3093–101.CrossRefPubMedGoogle Scholar
  2. 2.
    Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.CrossRefGoogle Scholar
  3. 3.
    Schmoor C, Sauerbrei W, Bastert G, Schumacher M. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol. 2000;18:1696–709.CrossRefPubMedGoogle Scholar
  4. 4.
    Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg. 2006;203:469–74.CrossRefPubMedGoogle Scholar
  5. 5.
    Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–37.CrossRefPubMedGoogle Scholar
  6. 6.
    Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node negative breast cancer. J Clin Oncol. 2009;27:2466–73.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. Available at: https://www.nccn.org/professionals/physician_gls/default.aspx. PDF version, page MS-53-55. Accessed 28 Oct 2018.
  8. 8.
    American Society of Clinical Oncology (ASCO). Quality and guidelines. Breast Cancer. Available at: https://www.asco.org/practice-guidelines/quality-guidelines/guidelines/breast-cancer. Accessed 10 Dec 2018.
  9. 9.
    Senkus E, Kyriakides S, Ohno S, ESMO Guidelines Committee, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(5):8–30.CrossRefGoogle Scholar
  10. 10.
    Cardoso F, Senkus E, Costa A, et al. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4). Ann Oncol. 2018;29:1634–57.CrossRefPubMedGoogle Scholar
  11. 11.
    Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.0, 2017 AWMF Registernummer: 032-045OL. Available at: http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/PDF version, page 198-201. Accessed 28 Oct 2018.
  12. 12.
    Haffty BG, Fischer D, Beinfield M, et al. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys. 1991;21:293–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Harris EE, Hwang WT, Seyednejad F, et al. Prognosis after regional lymph node recurrence in patients with stage I–II breast carcinoma treated with breast conservation therapy. Cancer. 2003;98:2144–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Tennant S, Evans A, Macmillan D, et al. CT staging of loco-regional breast cancer recurrence. A worthwhile practice? Clin Radiol. 2009;64:885–90.CrossRefPubMedGoogle Scholar
  15. 15.
    Touboul E, Buffat L, Belkacemi Y, et al. Local recurrences and distant metastases after breast conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25–38.CrossRefPubMedGoogle Scholar
  16. 16.
    Van Oost FJ, van der Hoeven JJ, Hoekstra OS, et al. Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography. Eur J Cancer. 2004;40:1545–53.CrossRefPubMedGoogle Scholar
  17. 17.
    Yi M, Kronowitz SJ, Meric-Bernstam F, et al. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer. 2011;117:916–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Neuman HB, Schumacher JR, Francescatti AB, The Alliance/American College of Surgeons Clinical Research Program Cancer Care Delivery Research Breast Cancer Surveillance Working Group, et al. Risk of synchronous distant recurrence at time of locoregional recurrence in patients with stage II and III breast cancer (AFT-01). J Clin Oncol. 2018;36:975–80.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Amann E, Huang DJ, Weber WP, et al. Disease-related surgery in patients with distant metastatic breast cancer. Eur J Surg Oncol. 2013;39:1192–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Güth U, Vetter M, Huang DJ, et al. Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendations for staging imaging of node negative, hormonal receptor negative disease. Ann Oncol. 2013;24:555–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Wadasadawala T, Vadgaonkar R, Bajpai J. Management of isolated locoregional recurrences in breast cancer: a review of local and systemic modalities. Clin Breast Cancer. 2017;17:493–502.CrossRefPubMedGoogle Scholar
  22. 22.
    Chand AR, Ziauddin MF, Tang SC. Can locoregionally recurrent breast cancer be cured? Clin Breast Cancer. 2017;17:326–35.CrossRefPubMedGoogle Scholar
  23. 23.
    Xiao W, Zou Y, Zheng S, et al. Primary tumor resection in stage IV breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2018;44:1504–12.CrossRefPubMedGoogle Scholar
  24. 24.
    Khan SA, DesJardin ESM. Readdressing the role of surgery of the primary tumor in de novo stage IV breast cancer. Cancer Treat Res. 2018;173:73–88.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Constanze Elfgen
    • 1
  • Seraina Margaretha Schmid
    • 2
    • 3
  • Christoph Johannes Tausch
    • 1
  • Giacomo Montagna
    • 4
  • Uwe Güth
    • 1
    • 3
    Email author
  1. 1.Department of Breast SurgeryBrust-Zentrum ZürichZurichSwitzerland
  2. 2.Breast Center St. Gallen, Location Spital GrabsGrabsSwitzerland
  3. 3.Department of Gynecology and ObstetricsUniversity Hospital Basel (UHB)BaselSwitzerland
  4. 4.Breast CenterUHBBaselSwitzerland

Personalised recommendations